Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request, 32572-32573 [2015-14000]

Download as PDF 32572 Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0577. The approval expires on May 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: June 3, 2015. Leslie Kux, Associate Commissioner for Policy. and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0788. The approval expires on May 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: June 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–14056 Filed 6–8–15; 8:45 am] [FR Doc. 2015–14057 Filed 6–8–15; 8:45 am] BILLING CODE 4164–01–P BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Food and Drug Administration [Document Identifier: HHS–OS–0990–New– 30D] [Docket No. FDA–2014–N–2294] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ‘‘Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUMMARY: On April 15, 2015, the Agency submitted a proposed collection of information entitled, ‘‘Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, tkelley on DSK3SPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:12 Jun 08, 2015 Jkt 235001 Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, has submitted an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB) for review and approval. The ICR is for a new collection. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public on this ICR during the review and approval period. DATES: Comments on the ICR must be received on or before July 9, 2015. ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Information Collection Clearance staff, Information.CollectionClearance@ hhs.gov or (202) 690–6162. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the Information Collection Request Title and document identifier HHS–OS– 0990–New–30D for reference. SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Information Collection Request Title: Midwest HIV Prevention and Pregnancy Planning Initiative (MHPPPI). Abstract: HHS Office of the Assistant Secretary for Health (OASH)/Office of Women’s Health (OWH) is seeking an approval on a new information collection request by the Office of Management and Budget (OMB), the program office initiatives on the evaluation of the MHPPPI will be conducted by the AIDS Foundation of Chicago’s (AFC) internal Research, Evaluation and Data Services (REDS) department, which specializes in documenting, evaluating and analyzing the process, impact and outcomes of health programs. The evaluation framework for MHPPPI includes process monitoring, impact evaluation, outcome evaluation and dissemination. The impact evaluation will be informed by an initial climate survey of a sample of medical providers within the Midwest to develop a conservative baseline estimate of the counterfactual model. The counterfactual model will postulate what would have happened without the intervention. The impact evaluation will also document and analyze the degree to which services are integrated in medical settings based on change agent surveys administered through participating trainees. The outcome evaluation will assess changes that occurred in each domain as a result of the intervention, including knowledge, attitudes and behaviors related to the specific training content. The overall evaluation goal is to assess whether or not MHPPPI: (1) Increased the knowledge of providers, (2) Facilitated the integration of pregnancy planning into the care of HIV-positive women/women with HIVpositive partners, and (3) Increased access to innovative HIV prevention options in communities with high HIV prevalence. Likely Respondents: Æ HIV Primary Care Providers D Anyone who provides primary HIV care to persons of reproductive age (15– 49) Æ Reproductive Health Care Providers D Anyone who provides reproductive health care to HIV+ persons or HIV¥ persons with HIV+ partners. Æ HIV-positive and HIV-negative women receiving reproductive health care E:\FR\FM\09JNN1.SGM 09JNN1 32573 Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of responses per respondent Number of respondents Form name Average burden per response (in hours) Total burden hours Provider Survey ............................................................................................... Patient Qualitative Interview ............................................................................ Provider Qualitative Interview .......................................................................... 300 20 20 1 1 1 15/60 1 1 75 20 20 Total .......................................................................................................... ........................ ........................ ........................ 105 tkelley on DSK3SPTVN1PROD with NOTICES Darius Taylor, Information Collection Clearance Officer. to NIDAOrgComments@mail.nih.gov by June 24, 2015. The statement should include the individual’s name, contact [FR Doc. 2015–14000 Filed 6–8–15; 8:45 am] information and, when applicable, BILLING CODE 4150–28–P professional affiliation. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND Dave Daubert, Deputy Executive Officer, HUMAN SERVICES National Institute on Drug Abuse, Office of Management, 6001 Executive National Institutes of Health Boulevard, NSC Building, Room 5274,Bethesda, MD 20892, 301–402– National Institute on Drug Abuse; 1652, daubert@nih.gov. Notice of Webinar Meeting SUPPLEMENTARY INFORMATION: The agenda for the web meeting will consist SUMMARY: Pursuant to the NIH Reform of updates made to the proposed Act of 2006 (42 U.S.C. Sec.281 (d)(4)), reorganization plans for the NIDA notice is hereby given that the National extramural program based on findings Institute on Drug Abuse (NIDA) will by the National Advisory Council on provide two opportunities to enable Drug Abuse. The proposal seeks to public discussion on the Institute’s bridge and integrate the key areas of proposal to reorganize its extramural translational neuroscience and program. neurobehavioral research, as well as DATES: Opportunity # 1: Beginning June capitalize on emerging scientific 12, 2015, the NIDA Director will make opportunities, while reducing barriers to available an online summary of the scientific and interdisciplinary proposed reorganization at: https:// collaboration. www.drugabuse.gov/about-nida/norasMembers of the public wishing to blog. Comments will be invited. attend the Webinar must view the Opportunity # 2: A public webinar discussion via webex link https:// will take place on June 19, 2015 at 3 nih.webex.com/nih/j.php?MTID p.m. Eastern Time, with attendance =mcc2b711f67cee4a9abe2b2a9c1d7 limited to space available. 8a0d and enter the audio conference ADDRESSES: Webex Meeting via: information above from their telephone. https://nih.webex.com/nih/j.php?MTID= Upon opening the link provided, please mcc2b711f67cee4a9abe2b2a9c1d78a0d. contact your IT support group for Participants are encouraged to join this assistance in uploading any necessary meeting at the link provided at least 20 drivers (e.g. MBR2 player) prior to the minutes prior to the scheduled start start of this event. time. Dated: June 3, 2015. Instructions for joining the event can Nora Volkow, be found below: 1. Enter the Web URL above into your Director, National Institute on Drug Abuse, National Institutes of Health. web browser address bar and hit enter. [FR Doc. 2015–14062 Filed 6–8–15; 8:45 am] 2. If requested, enter your name and BILLING CODE 4140–01–P email address. 3. If a password is required, enter the meeting password: Success1 DEPARTMENT OF HEALTH AND 4. Click ‘‘Join.’’ HUMAN SERVICES For audio support to this event, the audio conference information is as National Institutes of Health follows: Phone Number: 1–877–668–4493 Call- National Human Genome Research in toll-free number (US/Canada). Institute; Notice of Closed Meetings Participant Code No. 620 763 396. Pursuant to section 10(d) of the Any interested person may file Federal Advisory Committee Act, as written comments by sending an email VerDate Sep<11>2014 18:47 Jun 08, 2015 Jkt 235001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Genome Sequencing Program Coordinating Center (GSPCC). Date: June 23, 2015. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute 3rd Floor Conference Room, 5635 Fishers Lane Rockville, MD, (Telephone Conference Call). Contact Person: Lita Proctor, Ph.D., Extramural Research Programs Staff, Program Director, Human Microbiome Project, National Human Genome Research Institute 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892, 301 496–4550, proctorlm@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Sequencing Center RFAs. Date: July 20–21, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Arlington Capital View Hotel, Studio B, 2800 South Potomac Avenue, Arlington, VA 22202. Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer Scientific Review Branch, National Human Genome Research Institute 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, (301) 402–0838, pozzattr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 80, Number 110 (Tuesday, June 9, 2015)]
[Notices]
[Pages 32572-32573]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14000]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

[Document Identifier: HHS-OS-0990-New-30D]

Agency Information Collection Activities; Submission to OMB for
Review and Approval; Public Comment Request

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the Secretary (OS), Department of
Health and Human Services, has submitted an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB) for review and approval. The ICR is for a new collection.
Comments submitted during the first public review of this ICR will be
provided to OMB. OMB will accept further comments from the public on
this ICR during the review and approval period.

DATES: Comments on the ICR must be received on or before July 9, 2015.

ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via
facsimile to (202) 395-5806.

FOR FURTHER INFORMATION CONTACT: Information Collection Clearance
staff, Information.CollectionClearance@hhs.gov or (202) 690-6162.

SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the Information Collection Request Title
and document identifier HHS-OS-0990-New-30D for reference.
Information Collection Request Title: Midwest HIV Prevention and
Pregnancy Planning Initiative (MHPPPI).
Abstract: HHS Office of the Assistant Secretary for Health (OASH)/
Office of Women's Health (OWH) is seeking an approval on a new
information collection request by the Office of Management and Budget
(OMB), the program office initiatives on the evaluation of the MHPPPI
will be conducted by the AIDS Foundation of Chicago's (AFC) internal
Research, Evaluation and Data Services (REDS) department, which
specializes in documenting, evaluating and analyzing the process,
impact and outcomes of health programs. The evaluation framework for
MHPPPI includes process monitoring, impact evaluation, outcome
evaluation and dissemination. The impact evaluation will be informed by
an initial climate survey of a sample of medical providers within the
Midwest to develop a conservative baseline estimate of the
counterfactual model. The counterfactual model will postulate what
would have happened without the intervention. The impact evaluation
will also document and analyze the degree to which services are
integrated in medical settings based on change agent surveys
administered through participating trainees. The outcome evaluation
will assess changes that occurred in each domain as a result of the
intervention, including knowledge, attitudes and behaviors related to
the specific training content. The overall evaluation goal is to assess
whether or not MHPPPI:
(1) Increased the knowledge of providers,
(2) Facilitated the integration of pregnancy planning into the care
of HIV-positive women/women with HIV-positive partners, and
(3) Increased access to innovative HIV prevention options in
communities with high HIV prevalence.
Likely Respondents:
[cir] HIV Primary Care Providers
[ssquf] Anyone who provides primary HIV care to persons of
reproductive age (15-49)
[cir] Reproductive Health Care Providers
[ssquf] Anyone who provides reproductive health care to HIV+
persons or HIV- persons with HIV+ partners.
[cir] HIV-positive and HIV-negative women receiving reproductive
health care

[[Page 32573]]

Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Provider Survey................................. 300 1 15/60 75
Patient Qualitative Interview................... 20 1 1 20
Provider Qualitative Interview.................. 20 1 1 20
---------------
Total....................................... .............. .............. .............. 105
----------------------------------------------------------------------------------------------------------------

Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2015-14000 Filed 6-8-15; 8:45 am]
BILLING CODE 4150-28-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.